Wenliang Song, MD, MTR, FNLA serves as Director of Lipid Research at the Lifespan Cardiovascular Institute. As a physician-scientist, he specializes in general cardiology with an emphasis on preventative cardiology and lipid disorders. The Song Lab explores the complex interaction of bioactive lipids and lipoprotein particles, as well as synthetic lipoproteins as novel therapeutic tools. They investigate oxidized phospholipids, dicarbonyl scavengers, and the mechanisms behind omega-3 fatty acid supplementation for the cardiovascular system. Welcome, Dr. Song!